FDA inspectors find no issues at EDAP's manufacturing facility, putting the company one step closer to winning premarket approval for its ultrasound-based prostate cancer treatment.
News Well, Food & Drug Administration (FDA), Oncology, Pre-Market Approval (PMA), Prostate, Regulatory/Compliance, Ultrasound
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1rPE9b6
Cap comentari:
Publica un comentari a l'entrada